Scribe Therapeutics
Alameda, California, United StatesFounded 201799+ employeesPrivate
$120M raisedSeries A· last: convertible note (May 2023)· 3 rounds
Backed by(10 investors)
Prevail Therapeutics · LeadAvoro Ventures · LeadAndreessen Horowitz · LeadAvoro Capital Advisors · Lead+6 more
4 layoff events · Last: Nov 2025
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
